Company profile for Sionna Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sionna Therapeutics was formed in late 2019, leveraging 10 years of large pharma scientific investment and expertise. Our experienced scientific team has been on a mission to fully normalize CFTR function. In the three decades since the discovery of the genetic defects that cause cystic fibrosis (CF), researchers have made remarkable advances for patients. Yet the ultimate goal of CF drug development – to fully normalize ...
Sionna Therapeutics was formed in late 2019, leveraging 10 years of large pharma scientific investment and expertise. Our experienced scientific team has been on a mission to fully normalize CFTR function. In the three decades since the discovery of the genetic defects that cause cystic fibrosis (CF), researchers have made remarkable advances for patients. Yet the ultimate goal of CF drug development – to fully normalize the function of CFTR, the key protein leading to the pathology of CF – has remained out of reach.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
22 Strathmore Road Natick, MA 01760
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193348/0/en/Sionna-Therapeutics-to-Participate-in-Upcoming-December-Investor-Conferences.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181269/0/en/Sionna-Therapeutics-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180293/0/en/Sionna-Therapeutics-to-Participate-in-Upcoming-November-Investor-Conferences.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/24/3173007/0/en/Sionna-Therapeutics-Announces-Presentation-of-SION-719-and-SION-451-Phase-1-Data-and-Poster-of-New-Preclinical-Data-on-the-Impact-of-NBD1-Stabilizers-on-F508del-CFTR-Half-Life-at-t.html

GLOBENEWSWIRE
24 Oct 2025

https://www.globenewswire.com/news-release/2025/10/21/3170032/0/en/Sionna-Therapeutics-Announces-Initiation-of-PreciSION-CF-Phase-2a-Trial-Evaluating-NBD1-Stabilizer-SION-719-When-Added-to-Standard-of-Care-in-Participants-with-Cystic-Fibrosis.html

GLOBENEWSWIRE
21 Oct 2025

https://www.globenewswire.com/news-release/2025/10/01/3159914/0/en/Sionna-Therapeutics-to-Present-Data-at-the-2025-North-American-Cystic-Fibrosis-Conference.html

GLOBENEWSWIRE
01 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty